UK markets closed
NIKKEI 225
26,748.14 -253.38 (-0.94%) HANG SENG
20,112.10 -357.96 (-1.75%) CRUDE OIL
109.87 -0.42 (-0.38%) GOLD FUTURES
1,864.30 +16.50 (+0.89%) DOW
31,784.93 -95.31 (-0.30%) BTC-GBP
23,465.24 -689.20 (-2.85%)
Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:15PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.04B |
| Enterprise value | 2.14B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 36.38 |
| Price/book (mrq) | 3.31 |
| Enterprise value/revenue | 25.88 |
| Enterprise value/EBITDA | -7.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.90 |
| 52-week change 3 | -62.25% |
| S&P500 52-week change 3 | -5.12% |
| 52-week high 3 | 79.70 |
| 52-week low 3 | 20.24 |
| 50-day moving average 3 | 28.47 |
| 200-day moving average 3 | 40.58 |
Share statistics
| Avg vol (3-month) 3 | 540.94k |
| Avg vol (10-day) 3 | 725.15k |
| Shares outstanding 5 | 122.95M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 95.29M |
| % held by insiders 1 | 20.55% |
| % held by institutions 1 | 80.45% |
| Shares short (28 Apr 2022) 4 | 6.66M |
| Short ratio (28 Apr 2022) 4 | 15.36 |
| Short % of float (28 Apr 2022) 4 | 8.06% |
| Short % of shares outstanding (28 Apr 2022) 4 | 5.42% |
| Shares short (prior month 30 Mar 2022) 4 | 6.74M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -351.15% |
Management effectiveness
| Return on assets (ttm) | -12.68% |
| Return on equity (ttm) | -28.25% |
Income statement
| Revenue (ttm) | 82.88M |
| Revenue per share (ttm) | 0.68 |
| Quarterly revenue growth (yoy) | 431.90% |
| Gross profit (ttm) | -216.69M |
| EBITDA | -282.46M |
| Net income avi to common (ttm) | -285.76M |
| Diluted EPS (ttm) | -2.34 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 957.52M |
| Total cash per share (mrq) | 7.79 |
| Total debt (mrq) | 62.74M |
| Total debt/equity (mrq) | 6.84 |
| Current ratio (mrq) | 2.90 |
| Book value per share (mrq) | 7.47 |
Cash flow statement
| Operating cash flow (ttm) | -233.26M |
| Levered free cash flow (ttm) | 180.7M |
© 2022 Yahoo. All rights reserved.
